셀트리온 제약

Celltrion Pharm is one of Korea’s leading pharmaceutical companies, supplying both chemical and biopharmaceutical products to domestic and global markets. Our competitiveness is built on strong development capabilities and advanced manufacturing facilities. In particular, the Cheongju Plant is Korea’s first oral solid dosage manufacturing site to successfully pass GMP inspections by both the U.S. FDA and European regulatory authorities, establishing itself as a global chemical manufacturing hub capable of supplying tablet and capsule products worldwide. In addition to in-house product manufacturing, Celltrion Pharm also provides contract manufacturing services, including oral solid dosage (OSD) and prefilled syringe (PFS) drug product fill–finish CMO services, supported by globally certified GMP facilities and extensive commercial manufacturing experience.

"We are working to create a healthier tomorrow where no patients are left untreated."
Celltrion Pharm will continue to push its scientific and medical boundaries to help patients return to their everyday lives in full wellness.

"We innovate to provide more treatment options for patients around the world."
we have expanded treatment accessibility by supplying antibody biosimilars to the domestic market.
Celltrion Pharm will continue to broaden treatment areas by expanding its pharmaceutical offerings and strive to provide advanced therapeutic options that contribute to healthier and happier lives for people.